BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19024317)

  • 21. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
    Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
    Bradley J; Deasy JO; Bentzen S; El-Naqa I
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating thrombomodulin during radiation therapy of lung cancer.
    Hauer-Jensen M; Kong FM; Fink LM; Anscher MS
    Radiat Oncol Investig; 1999; 7(4):238-42. PubMed ID: 10492164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?
    Evans ES; Kocak Z; Zhou SM; Kahn DA; Huang H; Hollis DR; Light KL; Anscher MS; Marks LB
    Cytokine; 2006 Aug; 35(3-4):186-92. PubMed ID: 16979900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
    Müller G; Kiricuta IC; Stiess J; Bohndorf W
    Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid a as a predictive marker for radiation pneumonitis in lung cancer patients.
    Wang YS; Chang HJ; Chang YC; Huang SC; Ko HL; Chang CC; Yeh YW; Jiang JS; Lee CY; Chi MS; Chi KH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):791-7. PubMed ID: 22836061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
    Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
    Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
    Zhang XJ; Sun JG; Sun J; Ming H; Wang XX; Wu L; Chen ZT
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2103-16. PubMed ID: 22842662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.
    Anscher MS; Murase T; Prescott DM; Marks LB; Reisenbichler H; Bentel GC; Spencer D; Sherouse G; Jirtle RL
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):671-6. PubMed ID: 7928499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
    Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis.
    Liu Y; Xia T; Zhang W; Zhong Y; Zhang L; Wang X; Yu H
    Radiat Oncol; 2013 Jul; 8():189. PubMed ID: 23885707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation pneumonitis and early circulatory cytokine markers.
    Chen Y; Williams J; Ding I; Hernady E; Liu W; Smudzin T; Finkelstein JN; Rubin P; Okunieff P
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):26-33. PubMed ID: 11917281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery.
    Dang J; Li G; Zang S; Zhang S; Yao L
    Lung Cancer; 2014 Dec; 86(3):329-33. PubMed ID: 25454199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
    Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
    J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.